Colchicine plus ursodeoxycholic acid (UDCA) vs UDCA
Serious adverse events (proportion) · people with primary biliary cholangitis
It is very uncertain whether colchicine plus ursodeoxycholic acid (UDCA) changes serious adverse events (proportion) compared with UDCA (very low certainty).
1 finding from 1 review
- Pharmacological interventions for primary biliary cholangitis 2017 · Cochrane Headline outcomes onlyOR 3.08 [0.12, 78.14]1 study · 74 participantsVery low